← Eichor
Condition: Recurrent Vulvar Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Recurrent Vulvar Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Danish Vulva Cancer Recurrence Study
NA · 2 location(s) · University of Aarhus · NCT06495554
A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent a
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07424664
AK104 for Recurrent or Metastatic Vulvar Cancer
Phase 2 · 6 location(s) · Akeso · NCT05932212
A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurr
Phase 2 · 27 location(s) · Yonsei University · NCT06023862
Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies
NA · 1 location(s) · CNAO National Center of Oncological Hadrontherapy · NCT05457595
Electrochemotherapy for Recurrent Vulvar Cancer
Phase 2 · 1 location(s) · Institute of Oncology Ljubljana · NCT07443475
A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal C
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06292689
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
Phase 2 · 2 location(s) · Dana-Farber Cancer Institute · NCT06677190
Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer
Phase 2 · 15 location(s) · AGO Research GmbH · NCT05903833
Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer
Phase N/A · 1 location(s) · Affidea Nu-med Center of Oncological DIagnostics and Therapy · NCT07667192
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.